Option Care Health Stock-Based Compensation Growth & History (OPCH)
Option Care Health's stock-based compensation was $40.0M for fiscal 2025.
View full Option Care Health company overviewOption Care Health annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $40.0M | $3.8M | +10.55% |
| 2024 | 2024-12-31 | $36.1M | $5.7M | +18.58% |
| 2023 | 2023-12-31 | $30.5M | $13.7M | +81.61% |
| 2022 | 2022-12-31 | $16.8M | $7.2M | +75.28% |
| 2021 | 2021-12-31 | $9.6M | $6.7M | +227.91% |
| 2020 | 2020-12-31 | $2.9M | −$1.3M | −29.98% |
| 2019 | 2019-12-31 | $4.2M | $2.0M | +94.95% |
| 2018 | 2018-12-31 | $2.1M | $684,000 | +47.01% |
| 2017 | 2017-12-31 | $1.5M | −$346,000 | −19.21% |
| 2016 | 2016-12-31 | $1.8M | −$2.7M | −60.09% |
| 2015 | 2015-12-31 | $4.5M | −$4.1M | −47.34% |
| 2014 | 2014-12-31 | $8.6M | −$880,000 | −9.31% |
| 2013 | 2013-12-31 | $9.4M | $3.3M | +54.36% |
| 2012 | 2012-12-31 | $6.1M | $1.7M | +37.05% |
| 2011 | 2011-12-31 | $4.5M | $1.1M | +34.55% |
| 2010 | 2010-12-31 | $3.3M | −$99,000 | −2.90% |
| 2009 | 2009-12-31 | $3.4M | −$371,000 | −9.79% |
| 2008 | 2008-12-31 | $3.8M | $786,000 | +26.17% |
| 2007 | 2007-12-31 | $3.0M | — | — |
Option Care Health quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $8.4M | −$2.3M | −21.75% |
| Q1 2026 | 2026-03-31 | $10.2M | $1.4M | +15.88% |
| Q4 2025 | 2025-12-31 | $9.3M | $795,000 | +9.33% |
| Q3 2025 | 2025-09-30 | $11.1M | $718,000 | +6.90% |
| Q2 2025 | 2025-06-30 | $10.7M | $3.1M | +40.80% |
| Q1 2025 | 2025-03-31 | $8.8M | −$804,000 | −8.37% |
| Q4 2024 | 2024-12-31 | $8.5M | $952,000 | +12.57% |
| Q3 2024 | 2024-09-30 | $10.4M | $1.2M | +12.69% |
| Q2 2024 | 2024-06-30 | $7.6M | −$77,000 | −1.00% |
| Q1 2024 | 2024-03-31 | $9.6M | $3.6M | +60.40% |
| Q4 2023 | 2023-12-31 | $7.6M | $3.4M | +80.18% |
| Q3 2023 | 2023-09-30 | $9.2M | $5.2M | +130.59% |
| Q2 2023 | 2023-06-30 | $7.7M | $3.3M | +74.74% |
| Q1 2023 | 2023-03-31 | $6.0M | $1.8M | +43.32% |
| Q4 2022 | 2022-12-31 | $4.2M | $873,000 | +26.22% |
| Q3 2022 | 2022-09-30 | $4.0M | $1.5M | +59.18% |
| Q2 2022 | 2022-06-30 | $4.4M | $1.9M | +74.18% |
| Q1 2022 | 2022-03-31 | $4.2M | $3.0M | +246.72% |
| Q4 2021 | 2021-12-31 | $3.3M | $3.0M | +902.71% |
| Q3 2021 | 2021-09-30 | $2.5M | $1.3M | +115.04% |
| Q2 2021 | 2021-06-30 | $2.5M | $1.9M | +282.00% |
| Q1 2021 | 2021-03-31 | $1.2M | $448,000 | +59.18% |
| Q4 2020 | 2020-12-31 | $332,000 | $60,000 | +22.06% |
| Q3 2020 | 2020-09-30 | $1.2M | −$1.6M | −57.38% |
| Q2 2020 | 2020-06-30 | $661,000 | $92,000 | +16.17% |
| Q1 2020 | 2020-03-31 | $757,000 | $173,000 | +29.62% |
| Q4 2019 | 2019-12-31 | $272,000 | — | — |
| Q3 2019 | 2019-09-30 | $2.7M | — | — |
| Q2 2019 | 2019-06-30 | $569,000 | −$684,000 | −54.59% |
| Q1 2019 | 2019-03-31 | $584,000 | $28,000 | +5.04% |
| Q2 2018 | 2018-06-30 | $1.3M | $820,000 | +189.38% |
| Q1 2018 | 2018-03-31 | $556,000 | $35,000 | +6.72% |
| Q3 2017 | 2017-09-30 | $571,000 | −$783,000 | −57.83% |
| Q2 2017 | 2017-06-30 | $433,000 | −$86,000 | −16.57% |
| Q1 2017 | 2017-03-31 | $521,000 | −$953,000 | −64.65% |
| Q3 2016 | 2016-09-30 | $1.4M | $522,000 | +62.74% |
| Q2 2016 | 2016-06-30 | $519,000 | −$643,000 | −55.34% |
| Q1 2016 | 2016-03-31 | $1.5M | −$183,000 | −11.04% |
| Q4 2015 | 2015-12-31 | $862,000 | −$1.1M | −55.41% |
| Q3 2015 | 2015-09-30 | $832,000 | −$921,000 | −52.54% |
| Q2 2015 | 2015-06-30 | $1.2M | −$836,000 | −41.84% |
| Q1 2015 | 2015-03-31 | $1.7M | −$1.2M | −42.58% |
| Q4 2014 | 2014-12-31 | $1.9M | −$257,000 | −11.74% |
| Q3 2014 | 2014-09-30 | $1.8M | $326,000 | +22.85% |
| Q2 2014 | 2014-06-30 | $2.0M | −$1.9M | −48.24% |
| Q1 2014 | 2014-03-31 | $2.9M | $913,000 | +46.27% |
| Q4 2013 | 2013-12-31 | $2.2M | $466,000 | +27.03% |
| Q3 2013 | 2013-09-30 | $1.4M | −$260,000 | −15.41% |
| Q2 2013 | 2013-06-30 | $3.9M | $2.1M | +121.20% |
| Q1 2013 | 2013-03-31 | $2.0M | $1.0M | +104.24% |
| Q4 2012 | 2012-12-31 | $1.7M | $1.2M | +256.20% |
| Q3 2012 | 2012-09-30 | $1.7M | −$44,000 | −2.54% |
| Q2 2012 | 2012-06-30 | $1.7M | $625,000 | +55.80% |
| Q1 2012 | 2012-03-31 | $966,000 | −$166,000 | −14.66% |
| Q4 2011 | 2011-12-31 | $484,000 | −$110,000 | −18.52% |
| Q3 2011 | 2011-09-30 | $1.7M | $634,000 | +57.79% |
| Q2 2011 | 2011-06-30 | $1.1M | $295,000 | +35.76% |
| Q1 2011 | 2011-03-31 | $1.1M | $328,000 | +40.80% |
| Q4 2010 | 2010-12-31 | $594,000 | −$440,000 | −42.55% |
| Q3 2010 | 2010-09-30 | $1.1M | $200,000 | +22.30% |
| Q2 2010 | 2010-06-30 | $825,000 | $113,000 | +15.87% |
| Q1 2010 | 2010-03-31 | $804,000 | $28,000 | +3.61% |
| Q4 2009 | 2009-12-31 | $1.0M | — | — |
| Q3 2009 | 2009-09-30 | $897,000 | — | — |
| Q2 2009 | 2009-06-30 | $712,000 | — | — |
| Q1 2009 | 2009-03-31 | $776,000 | — | — |
Option Care Health stock-based compensation trends
Over the last five fiscal years, Option Care Health's stock-based compensation increased from $2.9M to $40.0M, a change of $37.0M. The latest reported quarter, Q2 2026, shows $8.4M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Option Care Health source filings ↗